Quote | Tango Therapeutics Inc. (NASDAQ:TNGX)
Last: | $7.47 |
---|---|
Change Percent: | 0.52% |
Open: | $7.63 |
Close: | $7.47 |
High: | $7.63 |
Low: | $7.38 |
Volume: | 556,776 |
Last Trade Date Time: | 05/21/2024 03:00:00 am |
News | Tango Therapeutics Inc. (NASDAQ:TNGX)
2024-05-08 13:53:49 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tango Therapeutics (NASDAQ: TNGX ) just reported results for the first quarter of 2024. Tango Therapeutics reported earnings per share of -35 cents. This was below the ana...
2024-05-08 09:52:13 ET More on Tango Therapeutics Seeking Alpha’s Quant Rating on Tango Therapeutics Historical earnings data for Tango Therapeutics Financial information for Tango Therapeutics Read the full article on Seeking Alpha For further...
Message Board Posts | Tango Therapeutics Inc. (NASDAQ:TNGX)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Tango Therapeutics Inc. Company Name:
TNGX Stock Symbol:
NASDAQ Market:
– Dose expansion initiated in TNG908 phase 1/2 clinical trial – – Dose expansion expected to initiate in TNG462 phase 1/2 clinical trial in 2Q 2024 – – Clinical data expected in 2H 2024 from PRMT5 program – – Dose escalation...
– Dose escalation ongoing in four clinical-stage precision oncology programs; TNG908 phase 1/2 clinical data expected in 2024 – – First patient dosed in phase 1/2 clinical trial of TNG348 in patients with BRCA1/2-mutant and other HRD+ cancers – –...